Get started
Author

Hugo Deleon de Lima

Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases
2020 · Laurindo Ferreira da Rocha Junior, Angela Luzia Branco Pinto Duarte, et al. · Immunology Letters · 11
Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry
2022 · Ana Paula Monteiro Gomides, Cleandro Pires de Albuquerque, et al. · Revista Brasileira de Reumatologia · 6
PDF
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis
2023 · Markus Bredemeier, Ângela L Duarte, et al. · Lara D. Veeken · 5
Treatment with biological therapy is associated with faster recovery and lower frequency of treatment switch among rheumatic patients with Chikungunya fever
2022 · Aline Ranzolin, Claudia Diniz Lopes Marques, et al. · Revista Brasileira de Reumatologia · 4
PDF
Immunolocalization of amylase in the midgut enterocytes of Periplaneta americana (Dictyoptera, Blattidae)
2003 · HUGO DELEON DE LIMA, M. V. Cruz, et al. · 3
AB0508 THE EFFECT OF COMBINATIONS OF CONVENTIONAL SYNTHETIC DMARDs ON THE SAFETY AND TREATMENT RETENTION OF BIOLOGIC AGENTS OR JAK INHIBITORS IN RHEUMATOID ARTHRITIS
2024 · S. Ramos, M. Bredemeier, et al. · Annals of the Rheumatic Diseases · 1
The influence of sex on the persistence of anti-TNF therapy as first biologic agent in rheumatoid arthritis and spondyloarthritis
2025 · MARKUS BREDEMEIER, MARINA SILVESTRI PAUWELZ, et al. · Congresso Brasileiro de Reumatologia
Drug Survival and Safety of Adalimumab, Etanercept and Infliximab as First Biologic Agents in Spondyloarthritis
2025 · Markus Bredemeier, Larissa Rodrigues Fauth, et al. · Congresso Brasileiro de Reumatologia
The Effect of Corticosteroids on the Risk of Serious Adverse Events in Rheumatoid Arthritis: Simulating a Randomized Controlled Trial
2025 · Markus Bredemeier, Alice de Moraes Baier, et al. · Congresso Brasileiro de Reumatologia
POS0640 ANTIMALARIALS AND THE RISK OF OCULAR ADVERSE EVENTS IN RHEUMATOID ARTHRITIS: LOOKING BEYOND THE RARE OccURRENCE OF DRUG INDUCED RETINOPATHY
2024 · M. Bredemeier, S. Estefano Ramos, et al. · Annals of the Rheumatic Diseases
Comparing the Safety of Adalimumab and Etanercept as First Biologic in Rheumatoid Arthritis: Simulating a Randomized Controlled Trial Using Data From Biobadabrasil Cohort
2024 · Markus Bredemeier, Marina Silvestri Pauwelz, et al. · Congresso Brasileiro de Reumatologia
PDF
Antimalarials and the Risk of Ocular Adverse Events in Rheumatoid Arthritis: Looking Beyond the Rare Occurrence of Drug Induced Retinopathy
2024 · Markus Bredmeier, Suelem Estefano Ramos, et al. · Congresso Brasileiro de Reumatologia
PDF
The Risk Associated With the Interaction Between Smoking and Methotrexate in Rheumatic Patients on Therapy With Anti-tnf Agents
2024 · MARKUS BREDMEIER, ALICE DE MORAES BAIER, et al. · Congresso Brasileiro de Reumatologia
PDF
THE EFFECT OF COMBINATIONS OF CONVENTIONAL SYNTHETIC DMARDs ON THE SAFETY AND TREATMENT RETENTION OF BIOLOGIC AGENTS OR JAK INHIBITORS IN RHEUMATOID ARTHRITIS
2024 · ALINE RANZOLIN, RICARDO MACHADO XAVIER, et al.
PDF
Op0223 the Effect of Antimalarials on the Risk and Severity of Bacterial, Viral, Fungal and Systemic-specific Infections in Rheumatoid Arthritis
2023 · M. Bredemeier, M. Campos, et al. · Annals of the Rheumatic Diseases
PDF
Ab0428 Safety and Persistence of Treatment With Golimumab Versus Certolizumab in Rheumatoid Arthritis: Results From Biobadabrasil Cohort Study.
2023 · M. Bredemeier, S. Ramos, et al. · Annals of the Rheumatic Diseases
PDF
Ab1289 Is There Higher Risk of Fatigue, Depression, Anxiety and Stress After Covid-19 in Patients With Immune-mediated Rheumatic Diseases? Data From the Reumacov Brasil Cohort
2023 · C. Marques, M. Pinheiro, et al. · Annals of the Rheumatic Diseases
PDF
The Effect of Antimalarials on the Risk and Severity of Bacterial, Viral, Fungal and Systemic Specific Infections in Rheumatoid Arthritis
2023 · Markus Bredemeier, Monica Campos, et al. · Congresso Brasileiro de Reumatologia
PDF
Mapping Covid-19 Impact on Immune-mediated Rheumatic Diseases in Brazil S Macroregions: Reumacov Brasil Data
2023 · Claudia Diniz Lopes Marques, Adriana Maria Kakehasi, et al. · Congresso Brasileiro de Reumatologia
PDF
The Impact of Covid-19 in Patients With Systemic Vasculitides. Data From Reumacov Brazil Register
2023 · João Pedro de Matos Assunção, Gustavo Gomes Resende, et al. · Congresso Brasileiro de Reumatologia
PDF
Safety and Persistence of Treatment With Golimumab Versus Certolizumab in Rheumatoid Arthritis: Results From a Cohort Study
2023 · Markus Bredemeier, Suelem Ramos, et al. · Congresso Brasileiro de Reumatologia
PDF
Ab1173 Incident Cases of Covid-19 and Vaccination Adherence in a Multicentric Cohort of Inflammatory Arthritis in Brazil
2022 · S. M M de Souza, A.C. Medeiros-Ribeiro, et al. · Annals of the Rheumatic Diseases
PDF
Pos0650 the Impact of Old Age on the Persistence and Safety of Treatment With Biologic Agents or Jak Inhibitors in Rheumatoid Arthritis
2022 · R. Chakr, M. Bredemeier, et al. · Annals of the Rheumatic Diseases
PDF
Pos0242 the Effect of Antimalarials on the Overall Safety and Persistence of Treatment With Biologic Agents or Jak Inhibitors in Rheumatoid Arthritis
2022 · M. Bredemeier, A. Duarte, et al. · Annals of the Rheumatic Diseases
PDF
Multiple Myeloma Presenting as Small Vessel Vasculitis in a Patient With No Cryoglobulinemia: Case Report
2021 · Túlio Silva Freire, Villane Matheus Fernandes Silva, et al. · Congresso Brasileiro de Reumatologia
PDF
Works count: 37
Citation count: 30
H-index: 4
I10-index: 1
Year
Topic
Type